e-learning
resources
London 2016
Monday, 05.09.2016
Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Latent tuberculosis screening and entering antibody therapy monoclonares against tumor necrosis factor
Evangelina Soledad Membriani (Caba, Argentina), Evangelina Membriani, Erika Cuenca, Leticia Limongi, Ana Putruele, Carlos Luna
Source:
International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Session:
Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Session type:
Thematic Poster
Number:
2701
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Evangelina Soledad Membriani (Caba, Argentina), Evangelina Membriani, Erika Cuenca, Leticia Limongi, Ana Putruele, Carlos Luna. Latent tuberculosis screening and entering antibody therapy monoclonares against tumor necrosis factor. Eur Respir J 2016; 48: Suppl. 60, 2701
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Miliary tuberculosis during treatment with anti TNF alpha - a report of four cases
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Predictive factors of a delayed culture conversion under tuberculosis treatment
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014
Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015
Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014
Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Prevention of latent TB reactivation in rheumatology patients prior to anti-TNF therapy: Evaluation of a risk stratification strategy in a low prevalence area
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening
Source: International Congress 2014 – Tuberculosis epidemiology: novel features
Year: 2014
Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
Risk of tuberculosis in dialysis population: Revising the predictive value of interferon-gamma releasing assay
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value?
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept